| Mr Steven L Senica, MD | |
|
13060 Isle Dr, Baxter, MN 56425-8331 | |
| (218) 855-5473 | |
| (218) 454-5936 |
| Full Name | Mr Steven L Senica |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 31 Years |
| Location | 13060 Isle Dr, Baxter, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356419378 | NPI | - | NPPES |
| 036092176 | Medicaid | IL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 0369092176 (Illinois) | Secondary |
| 207V00000X | Obstetrics & Gynecology | 56720 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Essentia Health St Joseph's Medical Center | Brainerd, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Brainerd Medical Center Inc | 0648270272 | 26 |
News Archive
An international study, involving scientists at the University of Southampton, has used an analysis of epigenetic marks on DNA to measure how much a baby's development in the womb is determined by the genes inherited from the parents, as compared with the mother's nutrition, mental health and lifestyle.
A new scientific statement from the American Heart Association summarizes the state-of-the-science of genomic medicine - the study of the health effects of the molecular interactions of a person's unique genes - for studying cardiovascular traits and disorders and for therapeutic screening.
Opexa Therapeutics, Inc., a company developing Tovaxin, a novel T-cell therapy for multiple sclerosis, today presented important efficacy data at the American Academy of Neurology 63rd Annual Meeting.
Risk factors of type 2 diabetes and cardiovascular disease accumulate in children who have poor aerobic fitness, a new study from the University of Eastern Finland shows.
› Verified 4 days ago
| Entity Name | The Duluth Clinic Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902563638 PECOS PAC ID: 2567374283 Enrollment ID: O20031103000229 |
News Archive
An international study, involving scientists at the University of Southampton, has used an analysis of epigenetic marks on DNA to measure how much a baby's development in the womb is determined by the genes inherited from the parents, as compared with the mother's nutrition, mental health and lifestyle.
A new scientific statement from the American Heart Association summarizes the state-of-the-science of genomic medicine - the study of the health effects of the molecular interactions of a person's unique genes - for studying cardiovascular traits and disorders and for therapeutic screening.
Opexa Therapeutics, Inc., a company developing Tovaxin, a novel T-cell therapy for multiple sclerosis, today presented important efficacy data at the American Academy of Neurology 63rd Annual Meeting.
Risk factors of type 2 diabetes and cardiovascular disease accumulate in children who have poor aerobic fitness, a new study from the University of Eastern Finland shows.
› Verified 4 days ago
| Entity Name | St Marys Regional Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679561088 PECOS PAC ID: 2062326820 Enrollment ID: O20031117000090 |
News Archive
An international study, involving scientists at the University of Southampton, has used an analysis of epigenetic marks on DNA to measure how much a baby's development in the womb is determined by the genes inherited from the parents, as compared with the mother's nutrition, mental health and lifestyle.
A new scientific statement from the American Heart Association summarizes the state-of-the-science of genomic medicine - the study of the health effects of the molecular interactions of a person's unique genes - for studying cardiovascular traits and disorders and for therapeutic screening.
Opexa Therapeutics, Inc., a company developing Tovaxin, a novel T-cell therapy for multiple sclerosis, today presented important efficacy data at the American Academy of Neurology 63rd Annual Meeting.
Risk factors of type 2 diabetes and cardiovascular disease accumulate in children who have poor aerobic fitness, a new study from the University of Eastern Finland shows.
› Verified 4 days ago
| Entity Name | St Josephs Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568415974 PECOS PAC ID: 8224948443 Enrollment ID: O20031119000468 |
News Archive
An international study, involving scientists at the University of Southampton, has used an analysis of epigenetic marks on DNA to measure how much a baby's development in the womb is determined by the genes inherited from the parents, as compared with the mother's nutrition, mental health and lifestyle.
A new scientific statement from the American Heart Association summarizes the state-of-the-science of genomic medicine - the study of the health effects of the molecular interactions of a person's unique genes - for studying cardiovascular traits and disorders and for therapeutic screening.
Opexa Therapeutics, Inc., a company developing Tovaxin, a novel T-cell therapy for multiple sclerosis, today presented important efficacy data at the American Academy of Neurology 63rd Annual Meeting.
Risk factors of type 2 diabetes and cardiovascular disease accumulate in children who have poor aerobic fitness, a new study from the University of Eastern Finland shows.
› Verified 4 days ago
| Entity Name | Astera Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134305162 PECOS PAC ID: 2961395272 Enrollment ID: O20040202001082 |
News Archive
An international study, involving scientists at the University of Southampton, has used an analysis of epigenetic marks on DNA to measure how much a baby's development in the womb is determined by the genes inherited from the parents, as compared with the mother's nutrition, mental health and lifestyle.
A new scientific statement from the American Heart Association summarizes the state-of-the-science of genomic medicine - the study of the health effects of the molecular interactions of a person's unique genes - for studying cardiovascular traits and disorders and for therapeutic screening.
Opexa Therapeutics, Inc., a company developing Tovaxin, a novel T-cell therapy for multiple sclerosis, today presented important efficacy data at the American Academy of Neurology 63rd Annual Meeting.
Risk factors of type 2 diabetes and cardiovascular disease accumulate in children who have poor aerobic fitness, a new study from the University of Eastern Finland shows.
› Verified 4 days ago
| Entity Name | Astera Health |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1477545333 PECOS PAC ID: 2961395272 Enrollment ID: O20060504000722 |
News Archive
An international study, involving scientists at the University of Southampton, has used an analysis of epigenetic marks on DNA to measure how much a baby's development in the womb is determined by the genes inherited from the parents, as compared with the mother's nutrition, mental health and lifestyle.
A new scientific statement from the American Heart Association summarizes the state-of-the-science of genomic medicine - the study of the health effects of the molecular interactions of a person's unique genes - for studying cardiovascular traits and disorders and for therapeutic screening.
Opexa Therapeutics, Inc., a company developing Tovaxin, a novel T-cell therapy for multiple sclerosis, today presented important efficacy data at the American Academy of Neurology 63rd Annual Meeting.
Risk factors of type 2 diabetes and cardiovascular disease accumulate in children who have poor aerobic fitness, a new study from the University of Eastern Finland shows.
› Verified 4 days ago
| Entity Name | Ccm Health |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1720086028 PECOS PAC ID: 4284539453 Enrollment ID: O20060504000810 |
News Archive
An international study, involving scientists at the University of Southampton, has used an analysis of epigenetic marks on DNA to measure how much a baby's development in the womb is determined by the genes inherited from the parents, as compared with the mother's nutrition, mental health and lifestyle.
A new scientific statement from the American Heart Association summarizes the state-of-the-science of genomic medicine - the study of the health effects of the molecular interactions of a person's unique genes - for studying cardiovascular traits and disorders and for therapeutic screening.
Opexa Therapeutics, Inc., a company developing Tovaxin, a novel T-cell therapy for multiple sclerosis, today presented important efficacy data at the American Academy of Neurology 63rd Annual Meeting.
Risk factors of type 2 diabetes and cardiovascular disease accumulate in children who have poor aerobic fitness, a new study from the University of Eastern Finland shows.
› Verified 4 days ago
| Entity Name | International Falls Memorial Hospital Association |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1528041183 PECOS PAC ID: 1951365998 Enrollment ID: O20061104000465 |
News Archive
An international study, involving scientists at the University of Southampton, has used an analysis of epigenetic marks on DNA to measure how much a baby's development in the womb is determined by the genes inherited from the parents, as compared with the mother's nutrition, mental health and lifestyle.
A new scientific statement from the American Heart Association summarizes the state-of-the-science of genomic medicine - the study of the health effects of the molecular interactions of a person's unique genes - for studying cardiovascular traits and disorders and for therapeutic screening.
Opexa Therapeutics, Inc., a company developing Tovaxin, a novel T-cell therapy for multiple sclerosis, today presented important efficacy data at the American Academy of Neurology 63rd Annual Meeting.
Risk factors of type 2 diabetes and cardiovascular disease accumulate in children who have poor aerobic fitness, a new study from the University of Eastern Finland shows.
› Verified 4 days ago
| Entity Name | Brainerd Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295801777 PECOS PAC ID: 0648270272 Enrollment ID: O20070105000140 |
News Archive
An international study, involving scientists at the University of Southampton, has used an analysis of epigenetic marks on DNA to measure how much a baby's development in the womb is determined by the genes inherited from the parents, as compared with the mother's nutrition, mental health and lifestyle.
A new scientific statement from the American Heart Association summarizes the state-of-the-science of genomic medicine - the study of the health effects of the molecular interactions of a person's unique genes - for studying cardiovascular traits and disorders and for therapeutic screening.
Opexa Therapeutics, Inc., a company developing Tovaxin, a novel T-cell therapy for multiple sclerosis, today presented important efficacy data at the American Academy of Neurology 63rd Annual Meeting.
Risk factors of type 2 diabetes and cardiovascular disease accumulate in children who have poor aerobic fitness, a new study from the University of Eastern Finland shows.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Steven L Senica, MD 13060 Isle Dr, Baxter, MN 56425-8331 Ph: (218) 855-5473 | Mr Steven L Senica, MD 13060 Isle Dr, Baxter, MN 56425-8331 Ph: (218) 855-5473 |
News Archive
An international study, involving scientists at the University of Southampton, has used an analysis of epigenetic marks on DNA to measure how much a baby's development in the womb is determined by the genes inherited from the parents, as compared with the mother's nutrition, mental health and lifestyle.
A new scientific statement from the American Heart Association summarizes the state-of-the-science of genomic medicine - the study of the health effects of the molecular interactions of a person's unique genes - for studying cardiovascular traits and disorders and for therapeutic screening.
Opexa Therapeutics, Inc., a company developing Tovaxin, a novel T-cell therapy for multiple sclerosis, today presented important efficacy data at the American Academy of Neurology 63rd Annual Meeting.
Risk factors of type 2 diabetes and cardiovascular disease accumulate in children who have poor aerobic fitness, a new study from the University of Eastern Finland shows.
› Verified 4 days ago
Dr. Patricia Segler, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 13060 Isle Dr, Baxter, MN 56425 Phone: 218-454-5935 | |
Dr. Pamela Kay Rice, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 13060 Isle Dr, Baxter, MN 56425 Phone: 218-855-5473 Fax: 218-454-5936 | |
Hal M Leland, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 13060 Isle Dr, Baxter, MN 56425 Phone: 218-828-2880 | |
Alicia M Prahm, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 13060 Isle Dr, Baxter, MN 56425 Phone: 218-828-7100 |